412 related articles for article (PubMed ID: 32593682)
1. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
Sun Y; Wang Q; Zhang Y; Geng M; Wei Y; Liu Y; Liu S; Petersen RB; Yue J; Huang K; Zheng L
J Hepatol; 2020 Sep; 73(3):603-615. PubMed ID: 32593682
[TBL] [Abstract][Full Text] [Related]
2. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.
Li JM; Zhou J; Xu Z; Huang HJ; Chen MJ; Ji JS
J Cell Biochem; 2018 Jul; 119(7):5143-5152. PubMed ID: 29143999
[TBL] [Abstract][Full Text] [Related]
4. The oncogenic miR-27a/BTG2 axis promotes obesity-associated hepatocellular carcinoma by mediating mitochondrial dysfunction.
Su Q; Xu ZX; Xiong ML; Li HY; Xu MY; Luo SZ
Neoplasma; 2022 Jul; 69(4):820-831. PubMed ID: 35532294
[TBL] [Abstract][Full Text] [Related]
5. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.
Li W; Xin X; Li X; Geng J; Sun Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):107585. PubMed ID: 34601333
[TBL] [Abstract][Full Text] [Related]
6. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.
Guo D; Li Y; Chen Y; Zhang D; Wang X; Lu G; Ren M; Lu X; He S
Cell Prolif; 2019 Jul; 52(4):e12628. PubMed ID: 31038266
[TBL] [Abstract][Full Text] [Related]
7. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
8. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.
Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT
Carcinogenesis; 2012 May; 33(5):1113-20. PubMed ID: 22362728
[TBL] [Abstract][Full Text] [Related]
9. MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling.
Tian J; Li J; Bie B; Sun J; Mu Y; Shi M; Zhang S; Kong G; Li Z; Guo Y
Toxicol Appl Pharmacol; 2021 Jun; 420():115522. PubMed ID: 33838155
[TBL] [Abstract][Full Text] [Related]
10. MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway.
Yang Y; Yang Z; Zhang R; Jia C; Mao R; Mahati S; Zhang Y; Wu G; Sun YN; Jia XY; Aimudula A; Zhang H; Bao Y
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34096570
[TBL] [Abstract][Full Text] [Related]
11. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
[TBL] [Abstract][Full Text] [Related]
12. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
[TBL] [Abstract][Full Text] [Related]
14. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X
J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833
[TBL] [Abstract][Full Text] [Related]
16. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
[TBL] [Abstract][Full Text] [Related]
18. Novel role of LINC01013/miR-6795-5p/FMNL3 axis in the regulation of hepatocellular carcinoma stem cell features.
Wang W; Xu S; Di Y; Zhang Z; Li Q; Guo K; Lv Y; Wang B
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):652-662. PubMed ID: 33847733
[TBL] [Abstract][Full Text] [Related]
19. Maternal obesity during pregnancy leads to adipose tissue ER stress in mice via miR-126-mediated reduction in Lunapark.
de Almeida-Faria J; Duque-Guimarães DE; Ong TP; Pantaleão LC; Carpenter AA; Loche E; Kusinski LC; Ashmore TJ; Antrobus R; Bushell M; Fernandez-Twinn DS; Ozanne SE
Diabetologia; 2021 Apr; 64(4):890-902. PubMed ID: 33501603
[TBL] [Abstract][Full Text] [Related]
20. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
